BANNOCKBURN, Ill., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will participate in the 43rd Annual J.P. Morgan Healthcare Conference, being held in San Francisco, on Monday, January 13, 2025, including a presentation at 1:30pm PT. The webcast and related presentation materials will be available online at https://investors.optioncarehealth.com.
About Option Care Health
Option Care Health is the nation’s largest independent provider of home and alternate site infusion services. With over 7,500 team members including more than 4,500 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and team members. To learn more, please visit our website at OptionCareHealth.com.
For Investor Inquiries:
Mike Shapiro
Chief Financial Officer
T: (312) 940-2538
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | US$28.26 |
| Daily Change: | -1.09 -3.71 |
| Daily Volume: | 1,806,411 |
| Market Cap: | US$4.630B |
July 30, 2025 April 29, 2025 February 26, 2025 October 30, 2024 | |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORE
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
